How to Minimize Heart Problems Following Cancer Treatment

As more people are surviving cancer than ever before, greater attention is being focused on the cardiotoxicity of therapies and their long-term effects on the heart.   “There’s a lot we can do to prevent and manage heart disease, no matter what your cancer treatment history is,” says Jenica Upshaw, MD, a cardio-oncologist at Beth-Israel Deaconess Medical Center (BIDMC).    Cardio-oncologists … Read more

Daraxonrasib for Pancreatic Cancer: A Q&A with Dana-Farber’s Brian Wolpin, MD, MPH 

The U.S. Food and Drug Administration has approved daraxonrasib for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.   “This is an exceptional moment for patients with pancreatic cancer,” says Brian Wolpin, MD, MPH, director of the Hale Family Center for Pancreatic … Read more

GLP-1 Medications and Cancer Risk: What We Know So Far

GLP-1 medications have received significant attention for their effectiveness in treating obesity and type 2 diabetes. More recently, researchers have begun exploring another question: Could these medications also affect cancer risk? While some studies suggest that GLP-1 medications may be associated with lower rates of certain cancers, researchers are still working to understand whether those … Read more

Singer, Actress Finds New Way to Use Her Voice After Colorectal Cancer  

From the time Lorna Brunelle was a child, belting songs into her hairbrush, she knew she belonged in the spotlight.   Over the years, Brunelle’s passion for acting and singing evolved into a career in education and coaching. She opened a performing arts school and now owns a theater in her hometown of Middleborough, MA.   When … Read more

Dana-Farber Science Inspires Trial of Drug Combo for Ovarian Cancer 

As a post-doctoral fellow, Elizabeth Stover, MD, PhD, wanted to understand how ovarian cancer cells become resistant to chemotherapy. Chemotherapy becomes less effective over time for most patients with metastatic ovarian cancer.   She ran an unbiased screen – a way to look at every gene in the human genome and see which ones protect ovarian … Read more

FDA Approves Personalized Blood-Test Guided Immunotherapy for Bladder Cancer, Backed by Dana-Farber Science 

When patients with bladder cancer complete treatment that is intended to cure the cancer, they may be left wondering if there is anything else they should do to keep the cancer from coming back. For patients with muscle invasive bladder cancer – where the disease is at a higher risk of coming back than early-stage … Read more

Patient Finds Reassurance and Support After Rare Cancer Diagnosis

When Will Verbits noticed a cut on the side of his foot in the summer of 2024, he wasn’t worried. The longtime administrator of special education assumed he’d somehow gotten a blister. He was happily looking forward to retirement, eager to brush up on his cooking skills. But, over time, a lesion developed and grew. … Read more

Patient Finds Joy in Retirement After Enrolling in a Clinical Trial  

Pathogens are tiny invaders of the body that can make people sick—something that Howard Heller, MD, MPH, has spent his entire career studying. Then, in 2024, Heller discovered at age 64 there was another kind of invader, growing slowly and uncontrollably in his own body: cancer.   “I’ve helped patients as an infectious disease specialist for … Read more

Finding Empowerment Through a Lynch Syndrome Diagnosis 

In April, Riley McDevitt received test results from her genetic counselor at Dana-Farber. Tests showed a diagnosis of Lynch syndrome and McDevitt knew exactly what she wanted to do after hearing the news: celebrate with her family over tacos. The diagnosis wasn’t entirely unexpected. “I have a family history of Lynch syndrome, so I’ve known … Read more

Doctor by Day, Patient by Night: Young Sarcoma Survivor Overcomes Life Interrupted 

Bilasan Hammo, MD, had just turned 30, and everything seemed set up for a successful move into adulthood. As she wrapped up her residency at Cleveland Clinic Children’s, she landed a prestigious fellowship in Boston Children’s Hospital’s Gastrointestinal-Nutrition Department. Heavily influenced by her father – who is also a pediatric gastroenterologist – the fellowship felt … Read more

Rapid Epigenetic Test Could Speed Diagnostics for Acute Leukemias

Acute leukemias are life-threatening blood conditions that need urgent treatment. Approved targeted therapies such as BCL2, IDH, and menin inhibitors have expanded treatment options for certain patients, but determining if a given patient might benefit from one of these treatments can take time. Doctors need to order multiple complex diagnostic workups that can take days … Read more